Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Malysz

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 17, 2016
Conditional genetic deletion of Ano1 in interstitial cells of Cajal impairs Ca<sup>2+</sup> transients and slow waves in adult mouse small intestineJohn Malysz, Simon J Gibbons, Siva A Saravanaperumal, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2009
In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profileJohn Malysz, Jens Halvard Grønlien, David J Anderson, et al.
American Journal of Physiology. Renal Physiology|January 4, 2013
TRPM4 channel: a new player in urinary bladder smooth muscle function in ratsAmy C Smith, Shankar P Parajuli, Kiril L Hristov, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligandsTao Li, William H Bunnelle, Keith B Ryther, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Journal of Medicinal Chemistry|October 4, 2011
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligandsMarc J C Scanio, Lei Shi, William H Bunnelle, et al.
British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.
Molecular Pharmacology|June 20, 2003
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of bindingRachel Davis-Taber, Eduardo J Molinari, Robert J Altenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2007
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivoDaniel B Timmermann, Jens Halvard Grønlien, Kathy L Kohlhaas, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 17, 2016
Conditional genetic deletion of Ano1 in interstitial cells of Cajal impairs Ca<sup>2+</sup> transients and slow waves in adult mouse small intestineJohn Malysz, Simon J Gibbons, Siva A Saravanaperumal, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2009
In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profileJohn Malysz, Jens Halvard Grønlien, David J Anderson, et al.
American Journal of Physiology. Renal Physiology|January 4, 2013
TRPM4 channel: a new player in urinary bladder smooth muscle function in ratsAmy C Smith, Shankar P Parajuli, Kiril L Hristov, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligandsTao Li, William H Bunnelle, Keith B Ryther, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Journal of Medicinal Chemistry|October 4, 2011
Structure-activity studies of diazabicyclo[3.3.0]octane-substituted pyrazines and pyridines as potent α4β2 nicotinic acetylcholine receptor ligandsMarc J C Scanio, Lei Shi, William H Bunnelle, et al.
British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.
Molecular Pharmacology|June 20, 2003
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of bindingRachel Davis-Taber, Eduardo J Molinari, Robert J Altenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2007
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivoDaniel B Timmermann, Jens Halvard Grønlien, Kathy L Kohlhaas, et al.
Pageof 5